Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'DYNORPHIN-A' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 196 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Caudle, RM; Mannes, AJ; Benoliel, R; Eliav, E; Iadarola, MJ
      Intrathecally administered cholera toxin blocks allodynia and hyperalgesiain persistent pain models

      JOURNAL OF PAIN
    2. Spadaccini, R; Temussi, PA
      Natural peptide analgesics: the role of solution conformation

      CELLULAR AND MOLECULAR LIFE SCIENCES
    3. Ronzoni, S; Peretto, L; Giardina, GAM
      Lead generation and lead optimisation approaches in the discovery of selective, non-peptide ORL-1 receptor agonists and antagonists

      EXPERT OPINION ON THERAPEUTIC PATENTS
    4. Knapp, PE; Itkis, OS; Zhang, LX; Spruce, BA; Bakalkin, G; Hauser, KF
      Endogenous opioids and oligodendroglial function: Possible autocrine/paracrine effects on cell survival and development

      GLIA
    5. Pesini, P; Pego-Reigosa, R; Tramu, G; Covenas, R
      Distribution of alpha-neoendorphin immunoreactivity in the diencephalon and the brainstem of the dog

      JOURNAL OF CHEMICAL NEUROANATOMY
    6. Sahley, TL; Nodar, RH
      A biochemical model of peripheral tinnitus

      HEARING RESEARCH
    7. Peckys, D; Hurd, YL
      Prodynorphin and kappa opioid receptor mRNA expression in the cingulate and prefrontal cortices of subjects diagnosed with schizophrenia or affectivedisorders

      BRAIN RESEARCH BULLETIN
    8. Fritzsche, M
      Are cannabinoid receptor knockout mice animal models for schizophrenia?

      MEDICAL HYPOTHESES
    9. Narita, M; Ozaki, S; Ioka, M; Mizoguchi, H; Nagase, H; Tseng, LF; Suzuki, T
      Different motivational effects induced by the endogenous mu-opioid receptor ligands endomorphin-1 and-2 in the mouse

      NEUROSCIENCE
    10. Abraham, KE; McGinty, JF; Brewer, KL
      Spinal and supraspinal changes in opioid mRNA expression are related to the onset of pain behaviors following excitotoxic spinal cord injury

      PAIN
    11. Ghelardini, C; Galeotti, N; Mannelli, LD; Cappelli, A; Anzini, M; Bartolini, A
      Antiamnesic effect of the two novel kappa-opioid agonists, VA-100 and VA-101, in the mouse passive avoidance test

      DRUG DEVELOPMENT RESEARCH
    12. Rady, JJ; Fujimoto, JM
      Confluence of antianalgesic action of diverse agents through brain interleukin(1 beta) in mice

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    13. Butelman, ER; Ko, MCH; Traynor, JR; Vivian, JA; Kreek, MJ; Woods, JH
      GR89,696: A potent kappa-opioid agonist with subtype selectivity in rhesusmonkeys

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    14. Rady, JJ; Holmes, BB; Tseng, LF; Fujimoto, JM
      Inverse agonist action of Leu-enkephalin at delta(2)-opioid receptors mediates spinal antianalgesia

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    15. Rady, JJ; Campbell, WB; Fujimoto, JM
      Antianalgesic action of nociceptin originating in the brain is mediated byspinal prostaglandin E-2 in mice

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    16. Ambo, A; Hamazaki, N; Yamada, Y; Nakata, E; Sasaki, Y
      Structure-activity studies on nociceptin analogues: ORL1 receptor binding and biological activity of cyclic disulfide-containing analogues of nociceptin peptides

      JOURNAL OF MEDICINAL CHEMISTRY
    17. Lu, YX; Nguyen, TMD; Weltrowska, G; Berezowska, I; Lemieux, C; Chung, NN; Schiller, PW
      [2 ',6 '-dimethyltyrosine]dynorphin A(1-11)-NH2 analogues lacking an N-terminal amino group: Potent and selective kappa opioid antagonists

      JOURNAL OF MEDICINAL CHEMISTRY
    18. Ishihara, S; Tsuchiya, S; Horie, S; Murayama, T; Watanabe, K
      Gastric acid secretion by central injection of dynorphin A-(1-17), an endogenous ligand of kappa-opioid receptor, in urethane-anesthetized rats

      JAPANESE JOURNAL OF PHARMACOLOGY
    19. Wu, H; Hung, K; Ohsawa, M; Mizoguchi, H; Tseng, LF
      Antisera against endogenous opioids increase the nocifensive response to formalin: demonstration of inhibitory beta-endorphinergic control

      EUROPEAN JOURNAL OF PHARMACOLOGY
    20. Matsumoto, H; Nagasaka, T; Hattori, A; Rogi, T; Tsuruoka, N; Mizutani, S; Tsujimoto, M
      Expression of placental leucine aminopeptidase/oxytocinase in neuronal cells and its action on neuronal peptides

      EUROPEAN JOURNAL OF BIOCHEMISTRY
    21. Tan-No, K; Ohshima, K; Taira, A; Inoue, M; Niijima, F; Nakagawasai, O; Tadano, T; Nylander, T; Silberring, J; Terenius, L; Kisara, K
      Antinociceptive effect produced by intracerebroventricularly administered dynorphin A is potentiated by p-hydroxymercuribenzoate or phosphoramidon inthe mouse formalin test

      BRAIN RESEARCH
    22. Sandrini, M; Romualdi, P; Vitale, G; Morelli, G; Capobianco, A; Pini, LA; Candeletti, S
      The effect of a paracetamol and morphine combination on dynorphin A levelsin the rat brain

      BIOCHEMICAL PHARMACOLOGY
    23. Shen, S; Ingenito, AJ
      Chronic blockade of hippocampal kappa receptors increases arterial pressure in conscious spontaneously hypertensive rats but not in normotensive Wistar Kyoto rats

      CLINICAL AND EXPERIMENTAL HYPERTENSION
    24. Holmes, DL; Thibaudeau, K; L'Archeveque, B; Milner, PG; Ezrin, AM; Bridon, DP
      Site specific 1 : 1 opioid : albumin conjugate with in vitro activity and long in vivo duration

      BIOCONJUGATE CHEMISTRY
    25. Hiramatsu, M; Inoue, K; Kameyama, T
      Dynorphin A-(1-13) and (2-13) improve beta-amyloid peptide-induced amnesiain mice

      NEUROREPORT
    26. De Stefano, R; Selvi, E; Villanova, M; Frati, E; Manganelli, S; Franceschini, E; Biasi, G; Marcolongo, R
      Image analysis quantification of substance P immunoreactivity in the trapezius muscle of patients with fibromyalgia and myofascial pain syndrome

      JOURNAL OF RHEUMATOLOGY
    27. Crain, SM; Shen, KF
      Antagonists of excitatory opioid receptor functions enhance morphine's analgesic potency and attenuate opioid tolerance/dependence liability

      PAIN
    28. Citterio, F; Corradini, L; Smith, RD; Bertorelli, R
      Nociceptin attenuates opioid and gamma-aminobutyric acid(B) receptor-mediated analgesia in the mouse tail-flick assay

      NEUROSCIENCE LETTERS
    29. Huang, XQ; Jiang, HL; Luo, XM; Chen, KX; Zhu, YC; Ji, RY; Cao, Y
      Study on mechanism of interaction of nociceptin and opioids binding with opioid receptor-like 1 receptor

      ACTA PHARMACOLOGICA SINICA
    30. Meunier, JC; Mouledous, L; Topham, CM
      The nociceptin (ORL1) receptor: molecular cloning and functional architecture

      PEPTIDES
    31. Reinscheid, RK; Nothacker, HP; Civelli, O
      The orphanin FQ/nociceptin gene: structure, tissue distribution of expression and functional implications obtained from knockout mice

      PEPTIDES
    32. Wright, RC; McConnaughey, MM; Ingenito, AJ
      Decreased dynorphin levels and increased kappa opioid receptor binding in male rats with isolation-induced hypertension

      PEPTIDES
    33. Xie, GX; Ito, E; Maruyama, K; Pietruck, C; Sharma, M; Yu, LC; Palmer, PP
      An alternatively spliced transcript of the rat nociceptin receptor ORL1 gene encodes a truncated receptor

      MOLECULAR BRAIN RESEARCH
    34. Wang, H; Wang, R; Nie, H; Zhang, RX; Qiao, JT
      Neurokinin A, calcitonin gene-related peptide, and dynorphin A (1-8) in spinal dorsal horn contribute to descending inhibition evoked by nociceptive afferent pathways: an immunocytochemical study

      REGULATORY PEPTIDES
    35. Almeida, FRC; Schivo, IRS; Lorenzetti, BB; Ferreira, SH
      Chronic intrathecal cannulation enhances nociceptive responses in rats

      BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
    36. Fairbanks, CA; Schreiber, KL; Brewer, KL; Yu, CG; Stone, LS; Kitto, KF; Nguyen, HO; Grocholski, BM; Shoeman, DW; Kehl, LJ; Regunathan, S; Reis, DJ; Yezierski, RP; Wilcox, GL
      Agmatine reverses pain induced by inflammation, neuropathy, and spinal cord injury

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    37. Mouledous, L; Topham, CM; Moisand, C; Mollereau, C; Meunier, JC
      Functional inactivation of the nociceptin receptor by alanine substitutionof glutamine 286 at the c terminus of transmembrane segment VI: Evidence from a site-directed mutagenesis study of the ORL1 receptor transmembrane-binding domain

      MOLECULAR PHARMACOLOGY
    38. Dumont, M; Lemaire, S
      Interactions of dynorphin A-(1-13) and nociceptin with cardiac D2 binding sites: Inhibition of ischemia-evoked release of noradrenaline from synaptosomal-mitochondrial fractions

      JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
    39. Kumar, V; Murray, TF; Aldrich, JV
      Extended TIP(P) analogues as precursors for labeled delta-opioid receptor ligands

      JOURNAL OF MEDICINAL CHEMISTRY
    40. Schlechtingen, G; Zhang, L; Maycock, A; DeHaven, RN; Daubert, JD; Cassel, J; Chung, NN; Schiller, PW; Goodman, M
      [Pro(3)]Dyn A(1-11)-NH2: A dynorphin analogue with high selectivity for the kappa opioid receptor

      JOURNAL OF MEDICINAL CHEMISTRY
    41. Mouledous, L; Topham, CM; Mazarguil, H; Meunier, JC
      Direct identification of a peptide binding region in the opioid receptor-like 1 receptor by photoaffinity labeling with [Bpa(10),Tyr(14)]nociceptin

      JOURNAL OF BIOLOGICAL CHEMISTRY
    42. Hiramatsu, M; Inoue, K
      Improvement by low doses of nociceptin on scopolamine-induced impairment of learning and/or memory

      EUROPEAN JOURNAL OF PHARMACOLOGY
    43. Hiramatsu, M; Inoue, K
      Des-tyrosine(1) dynorphin A-(2-13) improves carbon monoxide-induced impairment of learning and memory in mice

      BRAIN RESEARCH
    44. Houser, SJ; Eads, M; Embrey, JP; Welch, SP
      Dynorphin B and spinal analgesia: induction of antinociception by the cannabinoids CP55,940, Delta(9)-THC and anandamide

      BRAIN RESEARCH
    45. Okada, K; Sujaku, T; Chuman, Y; Nakashima, R; Nose, T; Costa, T; Yamada, Y; Yokoyama, M; Nagahisa, A; Shimohigashi, Y
      Highly potent nociceptin analog containing the Arg-Lys triple repeat

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    46. Russell, IJ
      Is fibromyalgia a distinct clinical entity? The clinical investigator's evidence

      BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
    47. Wang, JQ; McGinty, JF
      Glutamate-dopamine interactions mediate the effects of psychostimulant drugs

      ADDICTION BIOLOGY
    48. Spadaccini, R; Crescenzi, O; Picone, D; Tancredi, T; Temussi, PA
      Solution structure of dynorphin A (1-17): a NMR study in a cryoprotective solvent mixture at 278 K

      JOURNAL OF PEPTIDE SCIENCE
    49. Shen, S; Ingenito, AJ
      Depressor effect of kappa opioid agonist on hypertension induced by isolation in the rat

      CLINICAL AND EXPERIMENTAL HYPERTENSION
    50. Russell, IJ
      Neurochemical pathogenesis of fibromyalgia syndrome

      JOURNAL OF MUSCULOSKELETAL PAIN
    51. Goettl, VM; Tejwani, GA; Neff, NH; Hadjiconstantinou, M
      Decreased neuropeptide content in the spinal cord of aged rats: the effectof GM1 ganglioside

      NEUROREPORT
    52. Asai, Y; Watanabe, S
      Effect of a Dynorphin A analog, E2078, on phospholipid membrane properties

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    53. Romualdi, P; Bregola, G; Donatini, A; Capobianco, A; Simonato, M
      Region-specific changes in prodynorphin mRNA and ir-dynorphin A levels after kindled seizures

      JOURNAL OF MOLECULAR NEUROSCIENCE
    54. Shen, S; Ingenito, AJ
      Comparison of cardiovascular responses to intrahippocampal mu, delta and kappa opioid agonists in spontaneously hypertensive rats and isolation-induced hypertensive rats

      JOURNAL OF HYPERTENSION
    55. Goodman, CB; Heyliger, S; Emilien, B; Partilla, JS; Yang, HYT; Lee, CH; Cadet, JL; Rothman, RB
      Chronic exposure to antibodies directed against anti-opiate peptides alterdelta-opioid receptor levels

      PEPTIDES
    56. Martin-Kleiner, I; Bidlack, JM
      The synthetic kappa-opioid agonist (-)U50,488 does not affect calcium transport into R1.1 mouse thymoma cell line

      INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY
    57. King, APJ; Hall, KE; Macdonald, RL
      kappa- and mu-opioid inhibition of N-type calcium currents is attenuated by 4 beta-phorbol 12-myristate 13-acetate and protein kinase C in rat dorsalganglion neurons

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    58. Wan, Q; Murray, TF; Aldrich, JV
      A novel acetylated analogue of dynorphin A-(1-11) amide as a kappa-opioid receptor antagonist

      JOURNAL OF MEDICINAL CHEMISTRY
    59. Shirasu, N; Kuromizu, T; Nakao, H; Chuman, Y; Nose, T; Costa, T; Shimohigashi, Y
      Exploration of universal cysteines in the binding sites of three opioid receptor subtypes by disulfide-bonding affinity labeling with chemically activated thiol-containing dynorphin A analogs

      JOURNAL OF BIOCHEMISTRY
    60. Mason, DJ; Lowe, J; Welch, SP
      A diminution of Delta(9)-tetrahydrocannabinol modulation of dynorphin A-(1-17) in conjunction with tolerance development

      EUROPEAN JOURNAL OF PHARMACOLOGY
    61. Mason, DJ; Lowe, J; Welch, SP
      Cannabinoid modulation of dynorphin A: correlation to cannabinoid-induced antinociception

      EUROPEAN JOURNAL OF PHARMACOLOGY
    62. Horvath, G; Kekesi, G; Dobos, I; Szikszay, M; Klimscha, W; Benedek, G
      Effect of intrathecal agmatine on inflammation-induced thermal hyperalgesia in rats

      EUROPEAN JOURNAL OF PHARMACOLOGY
    63. Hiramatsu, M; Inoue, K
      Effects of nocistatin on nociceptin-induced impairment of learning and memory in mice

      EUROPEAN JOURNAL OF PHARMACOLOGY
    64. Hiramatsu, M; Inoue, K
      Nociceptin orphanin FQ and nocistatin on learning and memory impairment induced by scopolamine in mice

      BRITISH JOURNAL OF PHARMACOLOGY
    65. Mansouri, FA; Motamedi, F; Fathollahi, Y
      Chronic in vivo morphine administration facilitates primed-bursts-induced long-term potentiation of Schaffer collateral-CA1 synapses in hippocampal slices in vitro

      BRAIN RESEARCH
    66. Hruby, VJ; Agnes, RS
      Conformation-activity relationships of opioid peptides with selective activities at opioid receptors

      BIOPOLYMERS
    67. Schiller, PW; Weltrowska, G; Berezowska, I; Nguyen, TMD; Wilkes, BC; Lemieux, C; Chung, NN
      The TIPP opioid peptide family: Development of delta antagonists, delta agonists, and mixed mu agonist/delta antagonists

      BIOPOLYMERS
    68. Yan, CH; Digate, RJ; Guiles, RD
      NMR studies of the structure and dynamics of peptide E, an endogenous opioid peptide that binds with high affinity to multiple opioid receptor subtypes

      BIOPOLYMERS
    69. Hiramatsu, M; Murai, M; Kameyama, T
      Different modulation of cholinergic neuronal systems by dynorphin A (1-13)in carbon monoxide-exposed mice

      BIOCHEMICAL PHARMACOLOGY
    70. CHIPOT C; POHORILLE A
      CONFORMATIONAL EQUILIBRIA OF TERMINALLY BLOCKED SINGLE AMINO-ACIDS ATTHE WATER-HEXANE INTERFACE - A MOLECULAR-DYNAMICS STUDY

      JOURNAL OF PHYSICAL CHEMISTRY B
    71. HIRAMATSU M; KAMEYAMA T
      ROLES OF KAPPA-OPIOID RECEPTOR AGONISTS IN LEARNING AND MEMORY IMPAIRMENT IN ANIMAL-MODELS

      Methods and findings in experimental and clinical pharmacology
    72. YUFEROV VP; CULPEPPERMORGAN JA; LAFORGE KS; HO A; KREEK MJ
      REGIONAL QUANTITATION OF PREPRODYNORPHIN MESSENGER-RNA IN GUINEA-PIG GASTROINTESTINAL-TRACT

      Neurochemical research
    73. MILLER KE; SALVATIERRA AT
      APPOSITION OF ENKEPHALIN-IMMUNOREACTIVE AND NEUROTENSIN-IMMUNOREACTIVE NEURONS BY SEROTONIN-IMMUNOREACTIVE VARICOSITIES IN THE RAT SPINAL-CORD

      Neuroscience
    74. LING K; MA L; PEI G
      DIFFERENTIAL EFFICACIES OF KAPPA-AGONIST TO INDUCE HOMOLOGOUS DESENSITIZATION OF HUMAN KAPPA-OPIOID RECEPTOR

      Neuroscience letters
    75. NAQVI T; HAQ W; MATHUR KB
      STRUCTURE-ACTIVITY RELATIONSHIP STUDIES OF DYNORPHIN-A AND RELATED PEPTIDES

      Peptides (New York, N.Y. 1980)
    76. ITOH E; FUJIMIYA M; INUI A
      THIOPERAMIDE, A HISTAMINE H3 RECEPTOR ANTAGONIST, SUPPRESSES NPY-BUT NOT DYNORPHIN A-INDUCED FEEDING IN RATS

      Regulatory peptides
    77. ZHAI QZ; INGENITO AJ
      COMPARATIVE HYPOTENSIVE ACTIONS OF 3 NONPEPTIDE KAPPA-OPIOID AGONISTSON HIPPOCAMPUS OF SHRS AND NORMOTENSIVE WKY RATS

      Journal of cardiovascular pharmacology
    78. RADY JJ; HOLMES BB; FUJIMOTO JM
      SUPRASPINAL FLUMAZENIL INHIBITS THE ANTIANALGESIC ACTION OF SPINAL DYNORPHIN-A-(1-17)

      Pharmacology, biochemistry and behavior
    79. FABER ESL; CHAMBERS JP; EVANS RH
      SELECTIVE DEPRESSION OF DORSAL ROOT-EVOKED HIGH-THRESHOLD SYNAPTIC EXCITATION BY THE SELECTIVE KAPPA-OPIOID RECEPTOR AGONIST ENADOLINE IN THE NEONATAL RAT HEMISECTED SPINAL-CORD IN-VITRO

      Neuropharmacology
    80. ALT A; MANSOUR A; AKIL H; MEDZIHRADSKY F; TRAYNOR JR; WOODS JH
      STIMULATION OF GUANOSINE-5'-O-(3-[S-35]THIO)TRIPHOSPHATE BINDING BY ENDOGENOUS OPIOIDS ACTING AT A CLONED MU-RECEPTOR

      The Journal of pharmacology and experimental therapeutics
    81. HIRAMATSU M; MURASAWA H; NABESHIMA T; KAMEYAMA T
      EFFECTS OF U-50,488H ON SCOPOLAMINE-INDUCED, MECAMYLAMINE-INDUCED ANDDIZOCILPINE-INDUCED LEARNING AND MEMORY IMPAIRMENT IN RATS

      The Journal of pharmacology and experimental therapeutics
    82. RADY JJ; LIN W; FUJIMOTO JM
      PENTOBARBITAL ANTAGONISM OF MORPHINE ANALGESIA MEDIATED BY SPINAL CHOLECYSTOKININ

      The Journal of pharmacology and experimental therapeutics
    83. Su, X; Wachtel, RE; Gebhart, GF
      Inhibition of calcium currents in rat colon sensory neurons by K- but not mu- or delta-opioids

      JOURNAL OF NEUROPHYSIOLOGY
    84. UKAI M; SHINKAI N; KAMEYAMA T
      INVOLVEMENT OF DOPAMINE-RECEPTORS IN BENEFICIAL-EFFECTS OF TACHYKININS ON SCOPOLAMINE-INDUCED IMPAIRMENT OF ALTERNATION PERFORMANCE IN MICE

      European journal of pharmacology
    85. BELL KM; TRAYNOR JR
      DYNORPHIN A(1-8) - STABILITY AND IMPLICATIONS FOR IN-VITRO OPIOID ACTIVITY

      Canadian journal of physiology and pharmacology
    86. HIRAMATSU M; MURASAWA H; MORI H; KAMEYAMA T
      REVERSION OF MUSCARINIC AUTORECEPTOR AGONIST-INDUCED ACETYLCHOLINE DECREASE AND LEARNING IMPAIRMENT BY DYNORPHIN-A-(1-13), AN ENDOGENOUS KAPPA-OPIOID RECEPTOR AGONIST

      British Journal of Pharmacology
    87. SU MT; LIN WB; LUE WM; CHENG CY; TAO PL
      BLOCKADE OF THE DEVELOPMENT OF MORPHINE-TOLERANCE BY U-50,488, AN AVPANTAGONIST OR MK-801 IN THE RAT HIPPOCAMPAL SLICE

      British Journal of Pharmacology
    88. RUSSELL IJ
      ADVANCES IN FIBROMYALGIA - POSSIBLE ROLE FOR CENTRAL NEUROCHEMICALS

      The American journal of the medical sciences
    89. PAN ZZ
      MU-OPPOSING ACTIONS OF THE KAPPA-OPIOID RECEPTOR

      Trends in pharmacological sciences
    90. TESSMER MR; KALLICK DA
      ROLE OF TRYPTOPHAN-14 IN THE INTERACTION OF DYNORPHIN A(1-17) WITH MICELLES

      The journal of peptide research
    91. KREEK MJ
      CLINICAL UPDATE OF OPIOID AGONIST AND PARTIAL AGONIST MEDICATIONS FORTHE MAINTENANCE TREATMENT OF OPIOID ADDICTION

      Seminars in the neurosciences
    92. UKAI M; MIURA M; KAMEYAMA T
      DOPAMINERGIC INVOLVEMENT IN IMPROVING EFFECTS OF DYNORPHIN A-(1-13) ON GALANIN-INDUCED IMPAIRMENT OF PASSIVE-AVOIDANCE LEARNING IN MICE

      Human psychopharmacology
    93. UKAI M; MORI E; KAMEYAMA T
      MODULATORY EFFECTS OF MORPHINE, U-50488H AND 1,3-DI-(2-TOLYL)GUANIDINE ON COCAINE-LIKE DISCRIMINATIVE STIMULUS IN THE RAT USING 2-CHOICE DISCRETE-TRIAL AVOIDANCE PARADIGM

      Methods and findings in experimental and clinical pharmacology
    94. KOTZ CM; BILLINGTON CJ; LEVINE AS
      OPIOIDS IN THE NUCLEUS OF THE SOLITARY TRACT ARE INVOLVED IN FEEDING IN THE RAT

      American journal of physiology. Regulatory, integrative and comparative physiology
    95. XU JY; TSENG LF
      [MET]ENKEPHALIN IN THE SPINAL-CORD IS INVOLVED IN THE ANTINOCICEPTIONINDUCED BY INTRACEREBROVENTRICULARLY-ADMINISTERED ETORPHINE IN THE MOUSE

      Neuroscience
    96. LAUGHLIN TM; VANDERAH TW; LASHBROOK J; NICHOLS ML; OSSIPOV M; PORRECA F; WILCOX GL
      SPINALLY ADMINISTERED DYNORPHIN-A PRODUCES LONG-LASTING ALLODYNIA - INVOLVEMENT OF NMDA BUT NOT OPIOID RECEPTORS

      Pain
    97. NICHOLS ML; LOPEZ Y; OSSIPOV MH; BIAN D; PORRECA F
      ENHANCEMENT OF THE ANTIALLODYNIC AND ANTINOCICEPTIVE EFFICACY OF SPINAL MORPHINE BY ANTISERA TO DYNORPHIN-A(1-13) OR MK-801 IN A NERVE-LIGATION MODEL OF PERIPHERAL NEUROPATHY

      Pain
    98. HIRAMATSU M; HYODO T; KAMEYAMA T
      U-50,488H, A SELECTIVE KAPPA-OPIOID RECEPTOR AGONIST, AMELIORATES MEMORY IMPAIRMENTS INDUCED BY MUSCARINIC AUTORECEPTOR AGONIST, CARBACHOL IN MICE

      Neuroscience letters
    99. UKAI M; ITOH J; KOBAYASHI T; SHINKAI N; KAMEYAMA T
      EFFECTS OF THE KAPPA-OPIOID DYNORPHIN A(1-13) ON LEARNING AND MEMORY IN MICE

      Behavioural brain research
    100. HIRAMATSU M; SASAKI M; NABESHIMA T; KAMEYAMA T
      EFFECTS OF DYNORPHIN-A(1-13) ON CARBON MONOXIDE-INDUCED DELAYED AMNESIA IN MICE

      Pharmacology, biochemistry and behavior


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 05/06/20 alle ore 05:46:05